Jade Biosciences, Inc. (NASDAQ:JBIO) is held by 119 institutional investors per 13F filings through March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 31 Mar, 2026 | 7,085,423 | 190,935 | 2.77% | $99,550,194.00 |
| Janus Henderson Group Plc | 31 Mar, 2026 | 6,211,338 | 6,211,338 | 0.00% | $87,114,016.00 |
| Fairmount Funds Management LLC | 31 Mar, 2026 | 4,553,494 | 0 | 0.00% | $63,976,591.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Mar, 2026 | 3,671,083 | 0 | 0.00% | $51,578,716.00 |
| Bellevue Group AG | 31 Mar, 2026 | 3,501,502 | 160,399 | 4.80% | $49,196,103.00 |
| Venrock Adviser, LLC | 31 Mar, 2026 | 3,220,364 | 0 | 0.00% | $45,246,114.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 2,313,949 | -556,364 | -19.38% | $32,510,984.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,796,652 | 1,796,652 | 0.00% | $25,242,961.00 |
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 1,641,137 | 0 | 0.00% | $23,057,975.00 |
| Remedium Capital Partners, LLC | 31 Mar, 2026 | 1,577,750 | 0 | 0.00% | $22,167,388.00 |
| Versant Venture Management, LLC | 31 Mar, 2026 | 1,525,820 | 0 | 0.00% | $21,437,771.00 |
| Avidity Partners Management LP | 31 Mar, 2026 | 1,400,708 | 0 | 0.00% | $34,177,275.00 |
| Samsara BioCapital, LLC | 31 Mar, 2026 | 968,798 | 0 | 0.00% | $13,611,612.00 |
| GREAT POINT PARTNERS LLC | 31 Mar, 2026 | 964,462 | 158,189 | 19.62% | $13,550,691.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 944,776 | 69,503 | 7.94% | $13,274,106.00 |
| Aberdeen Group plc | 31 Mar, 2026 | 867,284 | 0 | 0.00% | $12,185,340.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 822,520 | -19,288 | -2.29% | $11,559,273.00 |
| Soleus Capital Management, L.P. | 31 Mar, 2026 | 796,744 | 0 | 0.00% | $11,194,253.00 |
| ACORN CAPITAL ADVISORS, LLC | 31 Mar, 2026 | 786,760 | 786,760 | 0.00% | $11,053,978.00 |
| State Street Corp | 31 Mar, 2026 | 655,690 | 12,769 | 1.99% | $9,212,445.00 |